in 10% of severe preeclampsia. It increases
plasma concentration and trombocyte
activation.
Data of Indonesian Health Ministry in 2010-2013
showed that hypertension was the second cause of
maternal mortality in Indonesia after bleeding
(Kemenkes RI, 2014). High rate of preeclampsia
must be followed by effective preventive and
treatment that still need a lot of researches.
Some researches for treatment and prevention of
preeclampsia can not be done in human. So we need
animal model that will be similar to preeclampsia.
The researches about animal model of preeclampsia
were very variated and need to be confirmed with
cellular and clininal examanations.
One of researches about preeclampsia animal
model was endothelialial dysfunction model. It was
made by Sulistyowati et. al. (2010) as induction of
preeclampsia. That endothelial dysfunction model
was done by injecting anti QA2 (anti Human QA
Lymphocyte Antigen 2 Region). It blocked QA2
expression in placenta.
Placental QA2 expression was homolog to
human leucocyte antigen-G expression (HLA-G) in
human. Low HLA-G in trophoblast was a predictor
to endothelial dysfunction in preeclampsia. That
reasearch showed that endotel dysfunction model in
Mus musculus cauesd HSP70, VCAM-1 and matrix
metalloproteinase (MMP9) profiles that were similar
with women with preeclampsia (Sulistyowati et. al.,
2010). That research did not examine clinical
examanations that appeared from endothelial
dysfunction.
The goal of this research was making endothelial
dysfunction in pregnant Mus musculus that was
injected by anti QA2 and confirming urine
examanation (protein, creatinine, and UACR urine)
as one of preeclampsia clinical manifestations
because of endothelial dysfunction and low renal
function.
2. MATERIAL DAN METHOD
This research was true experimental with post test
only with control group design. This research used
female Mus musculus that was mated by male Mus
musculus. Female Mus musculus with positive
vaginal plug were used in the research. The vaginal
plug was the sign those female and male Mus
musculus were mated and the pregnant was called 0
day.
Mus musculus that were used must be 3 months,
healthy, bodyweight 15-25 grams, well moving, no
wound found in the body, and clear eye. This
research used 3 pregant Mus musculus/groups. The
duration of research was 2 weeks, consisted of
acclimatization, mating female and male Mus
musculus, intervention, and termination.
All of female Mus musculus were injected by
pregnant mare serum gonadothropine (PMSG) and
human chorionic gonadotropine (HCG) to equate
oestrus cycle. Female Mus musculus was injected
by 5 IU PMSG intra peritoneal, after 48 hours they
were injected again by HCG 5 IU intra peritoneal.
After that, female Mus musculus were mated by
male Mus musculus 1:1.
Tomorow morning after mating, female and male
Mus musculus were seperated. Female Mus
musculus were examined if they had positive vaginal
plug or not. Pregnant Mus musculus were who had
positive vaginal plug, and randomize into 7 groups
(3 pregnant Mus musculus/group).
The location was in Laboratory of Embriology,
Faculty of Veterinery, Airlangga University. This
research consisted of 7 groups: K0 (control, no
injection of anti QA2), K1 (anti QA2 10 ng), K2
(anti QA2 20 ng), K3 (anti QA2 30 ng), K4 (anti
QA2 40 ng), K5 (anti QA2 50 ng), and K6 (anti
QA2 60 ng).
K1 was injected by anti QA2 10 ng (0,1 ml) intra
peritoneal in the first day of pregnant, and examined
in the second day of pregnant. K2 was injected by
anti QA2 10 ng (0,1 ml) intraperitoneal in the first
and second day of pregnant, and examined in the
third day of pregnant. K3 was
injected by anti QA2
10 ng (0,1 ml) intraperitoneal in the first, second,
and third day of pregnant, and examined in the
fourth day of pregnant. K4 was injected by anti
QA2 10 ng (0,1 ml) intra peritoneal in the first,
second, third, and fourth day of pregnant, and
examined in the fifth of pregnant. K5 was injected
by anti QA2 10 ng (0,1 ml) intra peritoneal in the
first, second, third, fourth, and fifth day of pregnant,
and examined in the sixth day of pregnant. K6 was
injected by anti QA2 10 ng (0,1 ml) intra peritoneal
in the first, second, third, fourth, fifth, and sixth day
of pregnant, and examined in the seventh day of
pregnant.
Urine of Mus musculus was tooken in the
morning and was examined for protein, creatinin,
and UACR to analyze endothelial dysfunction and
low renal function.